Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Ullmann

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 17, 2009
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trialsD L Horn, L Ostrosky-Zeichner, M I Morris, et al.
Mycoses|April 5, 2012
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitalsC T Rieger, O A Cornely, T Hoppe-Tichy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)M Sandherr, H Einsele, H Hebart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncologyW H Krüger, J Bohlius, O A Cornely, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infectionA J Ullmann, O A Cornely, A Burchardt, et al.
Bone Marrow Transplantation|January 12, 2010
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer studyR Herbrecht, J Maertens, L Baila, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2009
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patientsC Viscoli, R Herbrecht, H Akan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 19, 2015
ESCMID guideline for the diagnosis and treatment of biofilm infections 2014N Høiby, T Bjarnsholt, C Moser, et al.
Deutsche Medizinische Wochenschrift (1946)|December 18, 2001
[Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]A Böhme, M Ruhnke, M Karthaus, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 17, 2009
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trialsD L Horn, L Ostrosky-Zeichner, M I Morris, et al.
Mycoses|April 5, 2012
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitalsC T Rieger, O A Cornely, T Hoppe-Tichy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)M Sandherr, H Einsele, H Hebart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncologyW H Krüger, J Bohlius, O A Cornely, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infectionA J Ullmann, O A Cornely, A Burchardt, et al.
Bone Marrow Transplantation|January 12, 2010
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer studyR Herbrecht, J Maertens, L Baila, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2009
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patientsC Viscoli, R Herbrecht, H Akan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 19, 2015
ESCMID guideline for the diagnosis and treatment of biofilm infections 2014N Høiby, T Bjarnsholt, C Moser, et al.
Deutsche Medizinische Wochenschrift (1946)|December 18, 2001
[Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]A Böhme, M Ruhnke, M Karthaus, et al.
Pageof 5